Transplant pharmacists' opinions on generic product selection of critical-dose drugs

Factors considered important by transplant pharmacists in decisions about generic product selection and in defining critical-dose drugs, as well as transplant pharmacists' attitudes about bioequivalence testing, were studied. Surveys, completed by telephone and fax in 1997, were used to assess...

Ausführliche Beschreibung